Trial · NCT03338569
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With ICU Mortality | Placebo | 20 | Participants | ||
| Number of Participants With ICU Mortality | Intervention | 14 | Participants | ||
| All Cause Mortality at 28 Days | Placebo | 26 | Participants | ||
| All Cause Mortality at 28 Days | Intervention | 16 | Participants | ||
| Duration of Vasopressor Therapy | Placebo | 27.1 | Inter-Quartile Range 16.4 to 45.2 | hours | |
| Duration of Vasopressor Therapy | Intervention | 27.7 | Inter-Quartile Range 13.6 to 47.6 | hours | |
| Duration of ICU Stay Post Intervention Administration | Placebo | 2.6 | Inter-Quartile Range 1.5 to 5.3 | days | |
| Duration of ICU Stay Post Intervention Administration | Intervention | 2.9 | Inter-Quartile Range 1.8 to 7.5 | days | |
| Rate of Lactate Clearance Post Intervention Administration | Placebo | 24 hours | 13 | Participants | |
| Rate of Lactate Clearance Post Intervention Administration | Intervention | 24 hours | 12 | Participants | |
| Rate of Lactate Clearance Post Intervention Administration | Placebo | 48 hours | 18 | Participants | |
| Rate of Lactate Clearance Post Intervention Administration | Intervention | 48 hours | 16 | Participants | |
| Rate of Lactate Clearance Post Intervention Administration | Placebo | 72 hours | 18 | Participants | |
| Rate of Lactate Clearance Post Intervention Administration | Intervention | 72 hours | 18 | Participants | |
| Rate of Lactate Clearance Post Intervention Administration | Placebo | 96 hours | 19 | Participants | |
| Rate of Lactate Clearance Post Intervention Administration | Intervention | 96 hours | 18 | Participants | |
| Number of Participants With Need for Renal Replacement Therapy | Placebo | 2 | Participants | ||
| Number of Participants With Need for Renal Replacement Therapy | Intervention | 10 | Participants | ||
| Change in Serum Creatinine | Placebo | 0.5 | Inter-Quartile Range -0.1 to 0.7 | mg/dl | |
| Change in Serum Creatinine | Intervention | .4 | Inter-Quartile Range 0 to 0.7 | mg/dl |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03338569/results